About this trial
The study will test two behavioral intervention components to identify the combination of the two components that best supports people who inject drugs to achieve and sustain HIV viral load suppression.
The study design is a 2-to-the-2 factorial experiment. The 2 represents the level of each component: 0 (receive) or 1 (don't receive). The 2 represents the number of components being tested. The four components are: 1) receiving (or not receiving) peer support services for medication-assisted treatment (MAT) uptake and persistence and 2) behavioral activation therapy for depression (BAT). Therefore, in order to test which combination of components produce the best outcome, this factorial design randomizes people to 1 of 4 conditions. Each condition represents a possible combination of the 2 components above. All participants will receive patient navigation for care engagement.
Eligibility criteria
Qualifiers
be at least 18 years of age
be able to provide informed consent
be eligible to receive free HIV care services in Mexico
be HIV positive
Disqualifiers
has not injected drugs in the last 30 days or do not have a verifiable opioid use disorder
is not HIV positive
is receiving methadone
is unwilling to discuss methadone uptake with a peer
Trial design
Treatments tested in this trial
- Peer support to promote uptake and persistence of medication assisted treatment (MAT)
- Behavioral Activation Treatment (BAT) to reduce depression
- No Intervention Components
Treatment groups
Sponsors and collaborators
University of Texas, El Paso
Lead sponsor
University of California, San Francisco
Collaborator
Centro de Integracion Juvenil
Collaborator
El Centro Ambulatorio para la Prevención y Atención en SIDA e Infecciones de Transmisión Sexual
Collaborator